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interviews with 14 key informants including patients and their
spouses. Interview responses were recorded, transcribed and
organized thematically based on emerging codes using an induc-
tive analysis. Discussion with attending physicians, nurses, and
pharmacists at the clinic was also incorporated as data triangu-
lation. RESULTS: Potential problems in the patient-provider
communication included unfriendly welcoming or disgusted
reactions; disclosure of conﬁdential matters; and health care
environment factors. Compared with their previous experiences
at other health care facilities, the patients were very satisﬁed with
genuine and empathetic providers at this site. Moreover, they
perceived that the providers were more highly trained specialists
with effective communication skills, which encouraged the
patients to ask questions regarding their health. In addition, a
hotline number was provided so the patients could contact the
clinic whenever they encountered any health-related problems or
needed assistance. Thus, a trusted therapeutic rapport was estab-
lished with a positive impact on the patient-physician’s commit-
ment to care which resulted a good adherence. CONCLUSIONS:
Provider-patient communication contributes to patient satisfac-
tion with medical treatment which is extremely important in
HIV/AIDS care. As numerous issues facilitate or inhibit construc-
tive relationships between providers and patients, it is essential
for doctors to be aware of their power when dealing with
patients, particularly in this consumer empowerment era. Good
communication is essential to good practice of medicine and its
rewards are immeasurable for both patients and providers.
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OBJECTIVES: To assess the health-related quality of life
(HRQoL) among patients with venous leg ulcer (VLU) in the US
and UK. METHODS: A prospective, observational, multi-center
study was conducted among 112 patients with VLU in the US
(76 patients) and the UK (36 patients) between 2007 and 2008.
Patients completed a generic health status measure, the EuroQol
(EQ-5D) Questionnaire1 and a disease-speciﬁc health-related
quality of life measure, the Charing Cross Leg Ulcer Question-
naire2 at study baseline and at the end of the study. Patients
were provided routine medical care for their ulcer for a study
period of 12 weeks or until all their ulcers healed. Analyses
were conducted to assess the change in HRQoL scores over the
study period among all patients, among patients with all ulcers
healed (healed patients) and among patients with at least one
ulcer not healed (non-healed patients). RESULTS: The mean age
(SD) of VLU patients was 61.9 (13.7) years in the US and was
70.9 (13.9) years in the UK. A total of 51.3% of VLU patients
in the US were males while 36.1% in the UK were males. At
baseline, the mean (SD) EQ-5D index score was 0.6628
(0.2402) for US patients and 0.6206 (0.3413) for UK patients.
There was a statistically signiﬁcant improvement in EQ-5D
index scores over the study period among the US healed patients
(p < 0.01) but not for US non-healed patients or UK patients.
Among all patients, the Charing Cross Leg Ulcer Questionnaire
showed that patients’ social interaction (p < 0.01) and emo-
tional status (p < 0.01) were signiﬁcantly improved during the
study period. CONCLUSIONS: VLU results in a signiﬁcant
negative impact on patients’ health status. Treatments for VLU
that promote ulcer healing are likely to result in signiﬁcant
improvements in patients’ health-related quality of life. EU-08–
1532. © 2008 ER. Squibb & Sons, LL.C. 1 The EuroQuol
Group. www.euroqol.org; accessed 01/02/2007 2 Smith J, et al.
Measuring the quality of life in patients with venous leg ulcers.
J Vasc Surg 2000;31:642–9.
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OBJECTIVES: To document the psychometric properties and
estimate a minimal important difference (MID) for the Sinonasal
Outcome Test-16 (SNOT-16) in patients with acute bacterial
sinusitis. METHODS: Secondary psychometric analysis was
undertaken on data from a phase III trial to evaluate the efﬁcacy
and safety of moxiﬂoxacin over 5 consecutive days in the treat-
ment of acute bacterial sinusitis (N = 374). Trial patients also
completed the RAND SF-36, the Activity Impairment Assess-
ment (AIA) and a global rating of change. The SNOT-16 has 16
items and is scored as a uni-dimensional measure of symptoms
of rhinosinusitis. Internal consistency and construct validity
(against SF-36 and AIA) were assessed at baseline. Sensitivity and
MID were assessed by comparing test of cure data against base-
line using statistical methods (effect size (ES), standardised
response mean (SRM); and standard error of measurement
(SEM) and 1/2 standard deviation (1/2SD)) and anchor methods
against the smallest change on the global rating of change.
Missing data were imputed using last observation carried
forward. RESULTS: Internal consistency (a = 0.874) and con-
struct validity (SF-36 Role Function r = -0.44; Vitality r = 0.45,
Social Function r = 0.48, Pain r = 0.51, AIA r = 0.67 all P <
0.001) were conﬁrmed. The SNOT-16 was sensitive (ES = 1.68;
SRM = 1.36). The MID estimated by the anchor method was
-0.85; but MID was lower by distributional estimates
(SEM = 0.21, 1/2SD = 0.29). CONCLUSIONS: The study con-
ﬁrms the good psychometric properties of the SNOT-16 in
patients with acute bacterial sinusitis and demonstrates the sen-
sitivity and MID for this measure. The 3 MID estimates were
widely separated and the higher anchor based estimate was
settled on.
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OBJECTIVES: To document the psychometric properties and
estimate a minimal important difference (MID) for the Activity
Impairment Assessment (AIA) questionnaire in patients with
acute bacterial sinusitis. The AIA has previously been validated
in people with uncomplicated urinary tract infections.
METHODS: Secondary psychometric analysis was undertaken
on data from a phase III trial to evaluate the efﬁcacy and safety
of moxiﬂoxacin over 5 consecutive days in the treatment of acute
bacterial sinusitis (N = 374). Trial patients also completed the
RAND SF-36, the Sinonasal Outcomes Test-16 (SNOT-16) and a
global rating of change. The AIA has 5 items and is scored as a
uni-dimensional measure of the impact of disease on an individu-
al’s work or regular activities. Internal consistency and construct
validity (against SF-36 and SNOT-16) were assessed at baseline.
Sensitivity and MID were assessed by comparing test of cure data
against baseline using statistical methods (effect size (ES), stan-
dardised response mean (SRM); and standard error of measure-
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